Concurrent chemoradiotherapy combined with nimotuzumab in stage III–IVa nasopharyngeal carcinoma: a retrospective analysis

被引:0
|
作者
Zhuochen Cai
Dongni Chen
Wenze Qiu
Chixiong Liang
Yingying Huang
Jiayu Zhou
Zejiang Zhan
Yanqun Xiang
Xiang Guo
Xing Lv
机构
[1] Sun Yat-sen University Cancer Center,Department of Nasopharyngeal Carcinoma, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine
[2] Southern Medical University,Department of Thoracic Surgery, Nanfang Hospital
[3] Affiliated Cancer Hospital and Institute of Guangzhou Medical University,Department of Radiation Oncology
关键词
Nasopharyngeal carcinoma; Nimotuzumab; Concurrent chemoradiotherapy; Survival; Prediction model;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:2327 / 2344
页数:17
相关论文
共 50 条
  • [1] Concurrent chemoradiotherapy combined with nimotuzumab in stage III-IVa nasopharyngeal carcinoma: a retrospective analysis
    Cai, Zhuochen
    Chen, Dongni
    Qiu, Wenze
    Liang, Chixiong
    Huang, Yingying
    Zhou, Jiayu
    Zhan, Zejiang
    Xiang, Yanqun
    Guo, Xiang
    Lv, Xing
    [J]. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2023, 149 (06) : 2327 - 2344
  • [2] Nimotuzumab combined with concurrent chemoradiotherapy in locally advanced nasopharyngeal carcinoma: a retrospective analysis
    Liu, Zhi-gang
    Zhao, Yu
    Tang, Jiao
    Zhou, Yu-juan
    Yang, Wen-juan
    Qiu, Yan-fang
    Wang, Hui
    [J]. ONCOTARGET, 2016, 7 (17) : 24429 - 24435
  • [3] Nimotuzumab combined with concurrent chemoradiotherapy benefits patients with advanced nasopharyngeal carcinoma
    Li, Zhanzhan
    Li, Yanyan
    Yan, Shipeng
    Fu, Jun
    Zhou, Qin
    Huang, Xinqiong
    Shen, Liangfang
    [J]. ONCOTARGETS AND THERAPY, 2017, 10 : 5445 - 5458
  • [4] Efficacy and survival analysis of nimotuzumab combined with concurrent chemoradiotherapy in the treatment of locally advanced nasopharyngeal carcinoma
    Wang, Lili
    Zhuang, Hengzhao
    Xu, Xiaoyan
    Zhou, Juying
    Jiao, Yang
    [J]. FRONTIERS IN ONCOLOGY, 2023, 13
  • [5] Efficacy of concurrent chemoradiotherapy combined with nimotuzumab in the treatment of nasopharyngeal carcinoma with cervical lymph node metastasis
    Jinlong Lu
    Jiazhang Wei
    Xin Xiao
    Yunzhong Wei
    Min Li
    Yongta Huang
    Weiming Deng
    Hanwei Wang
    Zhi Gui
    Fei Liu
    He Jiang
    Jintao Zhang
    Jingjin Weng
    Shenhong Qu
    [J]. European Archives of Oto-Rhino-Laryngology, 2023, 280 : 2479 - 2488
  • [6] Efficacy of concurrent chemoradiotherapy combined with nimotuzumab in the treatment of nasopharyngeal carcinoma with cervical lymph node metastasis
    Lu, Jinlong
    Wei, Jiazhang
    Xiao, Xin
    Wei, Yunzhong
    Li, Min
    Huang, Yongta
    Deng, Weiming
    Wang, Hanwei
    Gui, Zhi
    Liu, Fei
    Jiang, He
    Zhang, Jintao
    Weng, Jingjin
    Qu, Shenhong
    [J]. EUROPEAN ARCHIVES OF OTO-RHINO-LARYNGOLOGY, 2023, 280 (05) : 2479 - 2488
  • [7] Efficacy of concurrent chemoradiotherapy combined with nimotuzumab for low-risk T4 stage nasopharyngeal carcinoma A pilot study
    Zhang, Shuai
    Huang, Xiaopeng
    Zhou, Liya
    Lin, Shaomin
    [J]. MEDICINE, 2018, 97 (38)
  • [8] A Prospective Study on Therapeutic Gain by Concurrent Chemoradiotherapy for Stage II-IVa Nasopharyngeal Carcinoma
    Mei, Qi
    Hu, Guangyuan
    Long, Guoxian
    Qiu, Hong
    Fu, Qiang
    Hu, Guoqing
    [J]. JOURNAL OF HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY-MEDICAL SCIENCES, 2011, 31 (01) : 58 - 61
  • [9] Effect of nimotuzumab and PF induction chemotherapy combined with concurrent chemoradiotherapy in treating locally advanced nasopharyngeal carcinoma
    Gao, Min
    Yuan, Tiejun
    Zhang, Fangxiang
    [J]. JOURNAL OF BUON, 2021, 26 (01): : 116 - 123
  • [10] A systematic analysis in efficacy and safety of nimotuzumab combined with chemoradiotherapy in treatment of advanced nasopharyngeal carcinoma
    Yunqin Sun
    Yaofeng Wang
    Liping Guan
    [J]. European Archives of Oto-Rhino-Laryngology, 2023, 280 : 1183 - 1190